Icade S.A.
CDMGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $1 | $2 |
| % Growth | -5% | 4% | -10.9% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 34.6% | 38.1% | 55.7% | 47.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $2 | -$0 | -$0 |
| Operating Expenses | $1 | $2 | $0 | $0 |
| Operating Income | -$0 | -$1 | -$0 | $1 |
| % Margin | -22.1% | -83.1% | -5.4% | 48.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$1 | -$0 | $1 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | -$0 | -$1 | $0 | $0 |
| % Margin | -19% | -81.8% | 3.7% | 24.3% |
| EPS | -3.64 | -17.53 | 0.71 | 5.33 |
| % Growth | 79.2% | -2,569% | -86.7% | – |
| EPS Diluted | -3.64 | -17.01 | 0.71 | 5.33 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | -$0 | $1 |
| % Margin | -11.1% | 18.2% | -4.6% | 37.2% |